Corneal neovascularization (CNV) means that new blood vessels—tiny red threads—grow into the normally clear, avascular surface of your eye. These vessels creep in when the cornea is starved of oxygen or chronically inflamed, turning once-transparent tissue cloudy, irritable and, if untreated, sight-threatening. Although CNV can look dramatic, modern science offers many ways to halt—or even reverse—those invading capillaries.
Your cornea—the clear “window” at the front of the eye—has no blood vessels in it. That natural absence of vessels keeps vision crisp and the tissue transparent. Corneal neovascularization (often shortened to CoNV) happens when new, abnormal blood vessels grow into this normally vessel-free zone. Think of it as small pipes pushing into a sheet of perfectly clean glass: the glass becomes cloudy, light scatters, and your eyesight suffers. Doctors consider CoNV a sight-threatening complication because once vessels enter the cornea, they can leak fluid, carry inflammatory cells, and lay down scar tissue that permanently blurs vision. These changes usually appear after the cornea has been “angered” or starved of oxygen for some time, upsetting the delicate chemical balance that keeps vessels out. EyeWiki
The cornea should be crystal-clear, with no blood vessels to scatter light. When infection, trauma, excessive contact-lens wear, autoimmune disease or chemical burns disrupt that balance, oxygen levels plunge and inflammatory alarms go off. The body responds by releasing growth signals such as vascular endothelial growth factor (VEGF); feeder vessels march in from the conjunctiva to “rescue” the cornea. Unfortunately, those vessels leak fats and plasma, boosting haze, scarring and graft-rejection risk. Anti-VEGF medications, limbal-stem-cell therapies and protective lifestyle tweaks all aim to stop that runaway process. Lippincott Journals
In a healthy eye, molecules that block vessel growth (anti-angiogenic factors) outweigh those that promote it (angiogenic factors). If the cornea becomes inflamed, infected, hypoxic (low oxygen), or physically injured, it releases spurts of angiogenic signals such as vascular endothelial growth factor (VEGF). Once those pro-growth molecules overpower the blockers, tiny capillaries begin to crawl in from the white part of the eye (the conjunctiva and limbus). Left unchecked, they branch deeper and wider, sometimes growing lymphatic vessels alongside blood vessels, leading to chronic swelling, lipid deposits, and scarring. Recent laboratory and imaging studies confirm this VEGF-driven switch and show how modern anti-VEGF drugs and laser techniques can sometimes reverse early growth. PMC
Main types you may hear about
Superficial or pannus neovascularization – Vessels stay in the topmost corneal layers, often creeping beneath the epithelium like tiny red threads. A classic cause is long-term contact-lens wear that starves the surface of oxygen.
Stromal (mid-depth) neovascularization – Capillaries dive a bit deeper into the corneal stroma. This pattern is typical after viral keratitis or chemical burns.
Deep (pre-Descemet) neovascularization – Vessels reach near the innermost corneal layer and can severely cloud vision; transplant rejection and longstanding inflammation are common culprits.
Lipid keratopathy–associated vessels – As new vessels leak, cholesterol and fats settle out, painting the cornea with white-yellow streaks; this secondary “lipid keratopathy” worsens haze. Review of Ophthalmology
Post-surgical neovascularization – Following corneal grafts, refractive surgery, or suturing, vessels may invade along wound tracks if healing is inflamed or sutures rub.
Common causes
Over-wearing soft contact lenses – Sleeping in, or wearing lenses for many hours reduces oxygen reaching the cornea; low oxygen flips the angiogenic switch and vessels crawl in from the edge. PMC
Tight or damaged contact lenses – Poorly fitting lenses rub and mechanically irritate the epithelium, adding inflammation to the hypoxia problem.
Bacterial keratitis – Micro-organisms such as Pseudomonas chew into the cornea; the immune system floods the area with inflammatory messengers that summon blood vessels for backup.
Herpes simplex viral keratitis – Recurrent “cold-sore virus” attacks trigger deep stromal inflammation, making the cornea call in vessels to help heal, but at the cost of clarity.
Herpes zoster ophthalmicus – Shingles virus in the ophthalmic nerve ignites intense corneal inflammation and vessel growth.
Fungal keratitis – Fungi penetrate deep layers, causing stubborn ulcers; chronic inflammation stimulates vascular ingrowth.
Traumatic corneal laceration – A penetrating cut triggers wound healing; new vessels frame and repair the defect but later scar, fogging vision.
Chemical burns (especially alkali) – Chemicals dissolve tissue barriers in seconds; emergency healing brings in vessels to deliver nutrients and immune cells.
Ultraviolet (UV-C) welding burn – “Arc eye” initially feels like gritty pain; repeated burns prompt chronic inflammation and neovascularization.
Chronic blepharitis and meibomian gland dysfunction – Inflamed eyelids shower the cornea with irritants, maintaining a low-grade insult that encourages vascular creep.
Severe dry-eye disease – Constant dryness scratches the surface, leading to micro-injuries and inflammatory vessel growth.
Pterygium extension onto the cornea – A wing-shaped growth from the conjunctiva drags in its own blood supply onto the corneal surface.
Limbal stem-cell deficiency – When the limbal “factory” that renews corneal cells fails (due to chemical burns, genetic disorders), blood vessels invade to fill the void.
Auto-immune ulcers (Mooren ulcer) – The body’s defence system mistakenly attacks the corneal periphery, and vessels arrive with inflammatory cells.
Stevens–Johnson syndrome and ocular cicatricial pemphigoid – Severe mucous-membrane diseases scar the ocular surface, letting vessels march in.
Corneal graft rejection – The recipient’s immune system recognises donor tissue as foreign, releasing signals that summon deep stromal vessels.
Suture-related irritation – Old or loose sutures behave like splinters, promoting local vessel growth along their tracks.
Keratoconus treated with hard contact lenses – Constant mechanical rubbing at the cone’s apex causes epithelial breaks and vessel entry.
Post-LASIK or PRK haze with inflammation – Though rare, chronic interface inflammation can invite micro-vessels toward the flap edge.
Advanced glaucoma or uveitis – Long-standing internal eye inflammation may spill over to the cornea, ushering in peripheral vessels.
Key symptoms
Blurry or hazy vision – Cloudy vessels scatter light like frosted glass.
Eye redness – Engorged feeder vessels at the limbus make the eye look bloodshot.
Foreign-body sensation – Rough new vessels under the surface feel scratchy with every blink.
Photophobia (light sensitivity) – Inflammation and surface irregularity cause painful glare in bright light.
Tearing or watering – Reflex tears attempt to soothe the irritated surface.
Ocular pain or soreness – Nerve endings fire in response to chronic inflammation.
Burning or stinging – Especially after contact-lens removal, due to oxygen rebound.
Decreased contrast sensitivity – Even if letters look clear, subtle shades blend together.
Halos around lights at night – Light scatters off abnormal vessels, creating rings.
Recurrent gritty feeling – Epithelial micro-erosions over vessel ridges mimic sand in the eye.
Eye fatigue – Straining to see through a hazy cornea tires ocular muscles quickly.
Reduced tolerance for contact lenses – Lenses rub against raised vessels, causing discomfort almost immediately.
Intermittent sharp pains – Tiny surface breaks near vessels can sting suddenly.
Cosmetic concern – Patients notice visible red streaks on what should be a clear, white cornea.
Slow visual recovery after blinking – Tear film struggles to smooth over bumpy vessel ridges, delaying clarity.
Diagnostic tests
A. Physical-exam and simple office assessments
Best-corrected visual-acuity test – Eye-chart reading quantifies how much sight has dropped.
External inspection with torch light – Quick look for feeder-vessel congestion and eyelid disease.
Slit-lamp biomicroscopy – High-powered microscope lets the ophthalmologist map vessel depth, branching, and leakage in vivid detail. PubMed
Fluorescein staining – Bright dye sticks to surface breaks, highlighting areas where vessels breach epithelium.
Intra-ocular pressure (tonometry) – Elevated pressure plus corneal vessels may hint at inflammatory glaucoma.
B. Manual or bedside functional tests
Schirmer tear test – Measures tear strip wetting to rule out dry-eye-related vascular growth.
Tear-break-up time (TBUT) – Records how quickly tears evaporate; unstable film suggests surface stress.
Eyelid eversion with cotton bud – Reveals hidden tarsal inflammation or follicles pointing toward allergic causes.
Corneal esthesiometry – A fine nylon thread touches the cornea to gauge sensation; reduced feeling may indicate herpes-related vessel growth.
Seidel test – Checks for aqueous leaks after trauma that might accompany vessel-rich scars.
C. Laboratory & pathological studies
Corneal scraping for culture and sensitivity – Identifies bacteria, fungi, or acanthamoeba that inflame and vascularise the cornea.
Polymerase-chain-reaction (PCR) for viral DNA – Pinpoints herpesviruses when standard cultures fall short.
Serum autoimmune panel (e.g., ANA, RF) – Screens for systemic diseases like rheumatoid arthritis driving ocular surface inflammation.
Complete blood count and ESR/CRP – Broad view of systemic infection or inflammation worsening CoNV.
Histopathology of excised corneal tissue – In rare cases, microscopic analysis reveals depth and nature of invading vessels and lipid deposits.
D. Electrodiagnostic tools
Visual evoked potential (VEP) – Measures brainwave response to visual stimuli; marked delay may suggest central involvement when haze is severe.
Electroretinography (ERG) – While mainly for retina, baseline ERG separates corneal from retinal contributions in unexplained vision loss.
E. Imaging and advanced diagnostics
Anterior-segment optical coherence tomography (AS-OCT) – Cross-section “ultrasound-like” light scan maps vessel depth and corneal thickness in microns. MDPI
Corneal OCT-angiography (OCT-A) – Software subtracts flow from OCT scans, painting a 3-D picture of tiny blood channels without dye. PMC
In-vivo confocal microscopy – Ultra-high magnification images individual endothelial cells and the smallest capillary loops that a slit lamp might miss. PubMed
Non-Pharmacological Treatments
Strict contact-lens holiday – removing lenses lets extra oxygen and tears reach the cornea, starving budding vessels of the hypoxia signal.
Switch to high-oxygen (SiHy) lenses – if lenses must resume, silicone-hydrogel models deliver 5-6× more oxygen, preventing recurrence.
Cold compresses – gentle cooling shrinks superficial vessels and calms itchy inflammation that feeds angiogenesis.
Frequent preservative-free artificial tears – dilute inflammatory cytokines, flush debris and lubricate micro-abrasions.
Lid-hygiene therapy – warm compresses and baby-shampoo scrubs clear bacterial toxins from eyelids, removing chronic surface stress.
Moisture-chamber goggles at night – trap humidity, stopping overnight dryness that triggers VEGF release.
UV-blocking wrap-around sunglasses – ultraviolet light up-regulates VEGF; blocking UV cuts that molecular “on” switch.
Smoking cessation – tobacco reduces conjunctival oxygen and adds free-radicals that stoke neovascular pathways.
Nutrient-dense, omega-3-rich diet – fish oils raise anti-angiogenic resolvins in tears.
Topical vitamin-C drops (10 % ascorbate) – antioxidant action mops up free radicals, slows vessel sprouting.
Therapeutic bandage contact lens (BCL) – a high-DK lens protects healing epithelium, letting nerves recover and inflammation settle.
PROSE or scleral lens – a large, vaulted lens bathes the cornea in fluid all day, creating a mechanical and oxygenated barrier.
Punctal plugs – conserve natural tears, lowering surface dryness that sparks new vessels.
Hyperbaric oxygen sessions – supersaturated plasma diffuses through peripheral cornea, reversing deep hypoxia.
Fine-needle diathermy (office procedure) – a micro-cautery needle seals feeding vessels, reducing leakage.
Argon-laser photocoagulation – heat from focused light obliterates deep stromal channels unresponsive to drops.
UV-A collagen cross-linking (CXL) – riboflavin-activated UV stiffens corneal collagen, sealing leaky clefts vessels use as tracks.
Photodynamic therapy (PDT) with verteporfin – a light-activated dye generates oxygen radicals that close abnormal vessels without burning adjacent tissue. PubMedScienceDirect
Amniotic-membrane graft (in-office or theater) – biological bandage delivers anti-inflammatory factors and a basement-membrane scaffold, discouraging neovascular cues.
Conjunctival flap repositioning – tucking the conjunctiva away from cornea strips vessels of their lifeline.
Evidence-Based Drug Treatments
Each medicine below lists class, usual adult dosage/frequency, usage period and key side-effects.
Prednisolone acetate 1 % drops – corticosteroid; 1–2 drops q2–4 h then taper; 2–6 weeks; may raise eye pressure or trigger cataract.
Bevacizumab 1 % topical – anti-VEGF monoclonal; 1 drop qid; 4–8 weeks; burning, rare corneal melt; dramatic vessel regression shown in RCTs. PubMedPubMed
Sub-conjunctival bevacizumab 1.25 mg/0.05 ml – office injection every 4–6 weeks; reaches deeper feeders; transient subconj hemorrhage. ScienceDirect
Ranibizumab 0.5 mg/ml topical – anti-VEGF fragment; 1 drop qid; four-week courses; low systemic absorption, rare ocular irritation.
Aflibercept 2 mg/0.05 ml intrastromal – VEGF-trap fusion protein; single or repeated injection; swelling, transient pain.
Cyclosporine-A 0.05 % emulsified drops – calcineurin inhibitor; 1 drop bid; chronic use; stinging, reversible redness.
Tacrolimus 0.03 % ointment – macrolide immunomodulator; nightly thin ribbon; 8–12 weeks; burning, mild blurred vision.
Doxycycline 100 mg orally bid – tetracycline; 4–6 weeks; blocks matrix-metalloproteinases that pave the way for vessels; sun-sensitivity, GI upset.
Ketorolac tromethamine 0.5 % drops – NSAID; 1 drop qid; 2-week pulses; temporary sting, less potent than steroids.
Sirolimus 0.2 % subconjunctival depot – mTOR inhibitor; slow-release implant every 2–3 months; targets inflammation and VEGF; foreign-body sensation.
Dietary Molecular Supplements
Omega-3 fish-oil (DHA/EPA 1000 mg/day) – anti-inflammatory resolvins damp VEGF.
Lutein 10 mg + Zeaxanthin 2 mg/day – carotenoids filter blue light, reduce oxidative stress.
Vitamin-A (retinyl palmitate 5000 IU/day) – supports epithelial barrier, limiting infection-triggered neovascularization.
Vitamin-C (ascorbate 500 mg bid) – regenerates other antioxidants and stabilizes collagen.
Vitamin-E (α-tocopherol 400 IU/day) – lipid-phase free-radical scavenger that guards cell membranes.
Zinc gluconate 25 mg/day – co-factor for metallo-enzymes that remodel corneal collagen properly.
Curcumin (turmeric extract 500 mg bid) – suppresses NF-κB inflammatory signaling.
Resveratrol 100 mg/day – polyphenol activates anti-angiogenic sirtuin pathways.
Green-tea EGCG 400 mg/day – blocks VEGF receptor-2 activation on endothelial cells.
Astaxanthin 6 mg/day – potent marine carotenoid lowers oxidative injury from UV.
(Always discuss supplements with an eye-care professional to avoid drug interactions.)
Regenerative / Stem-Cell / “Hard-Immunity” Therapies
Autologous serum eye-drops 20 % – four times daily; deliver growth factors and antibodies that rebuild epithelium.
Platelet-rich plasma (PRP) drops 40–60 % – qid; concentrate platelet-derived growth factor, speeding nerve and epithelial repair.
Cenegermin 20 µg/ml (rh-nerve-growth-factor) drops – six times per day for eight weeks; boosts corneal-nerve health, indirectly cooling inflammation.
Mesenchymal stem-cell–derived exosome drops – experimental qid regimen; nano-vesicles carry anti-angiogenic micro-RNAs.
Cultivated autologous limbal epithelial cells (CALEC) sheet – one-time operating-room placement; repopulates lost barrier cells and keeps blood vessels in the conjunctiva outside the cornea; 77 % surface-integrity success at 18 months. NatureReview of Ophthalmology
Umbilical-cord blood-serum drops 20 % – qid; rich in EGF and anti-VEGF cytokines, useful when patient serum is unsuitable.
Surgical Procedures
Simple Limbal Epithelial Transplantation (SLET) – a tiny strip of patient’s healthy limbus is glued onto amniotic membrane over the damaged cornea; those stem cells spread and re-create a clear, avascular surface within weeks. Equally effective as lab-cultured CLET. ScienceDirect
Conjunctival–Limbal Autograft (CLAU) – larger limbal graft for severe chemical burns; done under microscope; restores barrier and shuts down vessels.
Penetrating Keratoplasty (full-thickness corneal transplant) – removes opaque, vascularized tissue and replaces it with donor cornea; reserved for vision-limiting scarring.
Deep Anterior Lamellar Keratoplasty (DALK) – swaps only the stromal layer, sparing endothelium; lower rejection risk when vessels are superficial.
Boston Keratoprosthesis (KPro) – artificial corneal button for end-stage cases where grafts repeatedly fail.
Proven Prevention Tips
Limit daily contact-lens wear to < 14 hours and never sleep in lenses.
Choose high-oxygen silicone-hydrogel or daily-disposable lenses.
Treat dry-eye promptly with tears and lid hygiene.
Wear UV-blocking sunglasses outdoors, even on cloudy days.
Control allergies with antihistamine drops and indoor dust-mite measures.
Seek early care for red-eye infections—herpes, bacterial or fungal.
Stop smoking and avoid second-hand smoke.
Use safety goggles during chemical handling or sports.
Maintain a balanced, antioxidant-rich diet (see below).
Schedule yearly eye exams; sooner if symptoms flare.
When Should You See an Eye Doctor?
Any sudden redness, pain, light-sensitivity or new blurred vision demands same-week evaluation. If you wear contact lenses and notice pink strands on the white of the eye crawling onto the clear cornea, call within 48 hours. Post-transplant patients must alert their surgeon immediately if redness returns—vascular ingrowth often signals early rejection. Children with chronic eye rubbing or chemical injuries should be reviewed within 24 hours to protect developing vision.
Eating for Corneal Health
Smart Choices
Fatty fish (salmon, mackerel) for omega-3s
Leafy greens (spinach, kale) for lutein/zeaxanthin
Bright-orange veggies (carrots, pumpkin) for beta-carotene
Citrus fruits for vitamin-C
Nuts and seeds for vitamin-E and zinc
Turmeric-spiced dishes for curcumin
Green-tea drinks for EGCG
Berries (blueberry, strawberry) rich in anthocyanins
Whole grains for steady glucose and micronutrients
Plenty of pure water to keep tears flowing
Foods to Limit or Avoid
Trans-fats (deep-fried snacks) that boost inflammation
High-glycemic sweets spiking oxidative stress
Processed meats rich in nitrites (pro-angiogenic)
Excess alcohol dehydrating the ocular surface
Very salty foods worsening tear-film osmolarity
Smoking—technically not food, but avoid tobacco ingestion in any form
Energy drinks heavy in caffeine (tear evaporation)
White-bread heavy diets lacking antioxidants
Artificial-sweetener sodas (linked to metabolic stress)
Over-supplementation with vitamin-A (too much can be toxic)
Frequently Asked Questions
Can CNV go away on its own?
Mild, superficial vessels sometimes retract when the trigger—like contact-lens hypoxia—stops, but deep trunks require therapy.Is it contagious?
No; the process is your body’s response to stress or infection, not an infection itself.Do anti-VEGF eye-drops hurt?
They may sting briefly, but studies show excellent tolerance and vessel shrinkage after just a few weeks. PubMedPubMedWill steroid drops thin my cornea?
Long use can delay wound healing and raise eye pressure, so doctors taper dose and monitor regularly.Can I keep wearing lenses once vessels appear?
Usually you need a rest period; later, a high-oxygen daily lens may be possible under supervision.Are dietary supplements enough?
They are supportive, not curative. Combine them with medical therapy and lifestyle change.Is laser photocoagulation safe?
Modern argon lasers selectively seal vessels with minimal scarring, but deeper channels may recur.What is verteporfin PDT?
A light-activated drug that closes abnormal vessels without heat damage; useful when anti-VEGF alone is insufficient. PubMedHow successful are stem-cell grafts?
New CALEC data show a 77 % stable, clear surface after 18 months—a big leap for severe cases. NatureWill I need a full corneal transplant?
Only if vision-blocking scarring persists after vessel control.How long does recovery take?
Superficial cases improve in weeks; deep, chronic disease may need months and staged procedures.Can children develop CNV?
Yes—especially after chemical burns or vitamin-A deficiency; early treatment prevents amblyopia.Is PDT covered by insurance?
Policies vary; many insurers authorize it when vision is threatened and standard drugs have failed.Does CNV always cause pain?
Not always. Some patients notice only decreased clarity until vessels leak lipids, causing irritation.Can I drive with CNV?
If visual acuity meets legal standards and glare is minimal. Anti-glare coatings and proper treatment help.
Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.
The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members
Last Updated: August 01, 2025.
